Author: Li, Manci; Schifanella, Luca; Larsen, Peter A.
Title: Alu retrotransposons and COVID-19 susceptibility and morbidity Cord-id: sfz5abbd Document date: 2021_1_4
ID: sfz5abbd
Snippet: SARS-CoV-2 has spread rapidly across the world and is negatively impacting the global human population. COVID-19 patients display a wide variety of symptoms and clinical outcomes, including those attributed to genetic ancestry. Alu retrotransposons have played an important role in human evolution, and their variants influence host response to viral infection. Intronic Alus regulate gene expression through several mechanisms, including both genetic and epigenetic pathways. With respect to SARS-Co
Document: SARS-CoV-2 has spread rapidly across the world and is negatively impacting the global human population. COVID-19 patients display a wide variety of symptoms and clinical outcomes, including those attributed to genetic ancestry. Alu retrotransposons have played an important role in human evolution, and their variants influence host response to viral infection. Intronic Alus regulate gene expression through several mechanisms, including both genetic and epigenetic pathways. With respect to SARS-CoV-2, an intronic Alu within the ACE gene is hypothesized to be associated with COVID-19 susceptibility and morbidity. Here, we review specific Alu polymorphisms that are of particular interest when considering host response to SARS-CoV-2 infection, especially polymorphic Alu insertions in genes associated with immune response and coagulation/fibrinolysis cascade. We posit that additional research focused on Alu-related pathways could yield novel biomarkers capable of predicting clinical outcomes as well as patient-specific treatment strategies for COVID-19 and related infectious diseases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40246-020-00299-9.
Search related documents:
Co phrase search for related documents- ace expression and acute pneumonia ards respiratory distress syndrome: 1, 2
- ace expression and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- ace expression and adaptive immune response: 1
- ace inhibitor and acute pneumonia: 1, 2, 3
- ace inhibitor and acute pneumonia ards respiratory distress syndrome: 1
- ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
- ace inhibitor and low plasma: 1, 2
- acute pneumonia and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8
- acute pneumonia and additional research: 1, 2
- acute pneumonia and low plasma: 1, 2
- acute respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- acute respiratory distress syndrome and additional research: 1, 2, 3
- acute respiratory distress syndrome and additional study: 1, 2, 3, 4, 5, 6, 7
- acute respiratory distress syndrome and low plasma: 1, 2, 3, 4
- adaptive immune response and additional research: 1
- adaptive immune response and low plasma: 1
Co phrase search for related documents, hyperlinks ordered by date